GRN163L (imetelstat)

imetelstat · Geron Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GRN163L (imetelstat), covering 2015-12-24 to 2015-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD) [Phase 1]